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reflect the proper molecular weights of CD9 and CD81. At
the time of submission, gel analysis of CD9 and CD81 in the
exosomes using the NuPAGE gel system (Invitrogen Corp.,
Carlsbad, CA) indicated that the CD9 and CD81 had a lower
than expected molecular weight of 19 kDa. In collaboration
with Invitrogen Corp., the authors subsequently found that
CD9 and CD81 have a higher mobility in the NuPAGE system
and therefore giving them an apparent MW that was lower
than expected MW. The authors postulated that this higherDOI of original article: 10.1016/j.scr.2009.12.003.
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doi:10.1016/j.scr.2010.05.003mobility was due to the hydrophobicity of tetraspanin
membrane proteins. In the more commonly used Tris-glycine
gel systems from either Invitrogen or BioRad, they con-
firmed that the molecular weight of CD9 and CD 81 in our
exosomes was within their reported MW range of about 22-
27 kDa (Fig. A). The authors apologize for any inconvenience
and would like to reiterate that these errors do not alter the
findings or the conclusions of our report. For the readers’
convenience the Figure A and figure legend is produced
below:ang.lim@imb.a-star.edu.sg (S.K. Lim).
.
Figure A Apparentmolecularweight of CD9andCD81. Twoμg of exosomeswere resolvedon3 differentdifferent gel systems:NuPAGE4-
12% bis tris gel (Invitrogen Corp., Carlsbad, CA), ReadyGel 4-15% tris-HCl gel (Bio-RadLab., Philadelphia, PA) or Novex4-20% tris-glycine gel
(Invitrogen Corp.) before subjected towestern blot hybridyzation. The blotwas blocked and incubatedwithmouse anti-CD9 (1:60 dilution)
or mouse anti-CD81 (1:60) followed by horseradish peroxidase-coupled goat anti-mouse IgG (1:1250). All antibodies were obtained from
Santa Cruz Biotechnology, Santa Cruz, CA. The blot was then incubated with HRP-enhanced chemiluminescent substrate (Thermo Fisher
Scientific Inc., Waltham, MA) and then exposed to an X-ray film.
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